Healium Announces FDA Registration of Healium Clinical as a Class II 510(k)-Exempt Biofeedback Medical Device
FDA Registration Accelerates Healium Clinical's Expansion into Healthcare Settings Nationwide COLUMBIA, Mo., May 20, 2026 /PRNewswire/ -- For decades, biofeedback has relied on graphs and monitors. With this new FDA registration, a new generation of immersive technologies is transforming...
View original →